Description

Trivoglitor 2 Tablet is a medicine composed of Glimepiride, Metformin, and Voglibose. This combination is specifically designed for the treatment of type 2 diabetes mellitus. Glimepiride is a sulfonylurea that helps lower blood sugar levels by stimulating the release of insulin from the pancreas. Metformin is a biguanide that works by reducing the amount of sugar produced by the liver and increasing the sensitivity of muscle cells to insulin. Voglibose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels. Trivoglitor 2 Tablet is prescribed to individuals with type 2 diabetes to control their blood sugar levels. By regulating glucose metabolism and improving insulin sensitivity, it helps manage diabetes effectively. It is important to follow the recommended dosage and maintain a healthy lifestyle, including regular exercise and a balanced diet, to achieve optimal results.

Additional information